» Articles » PMID: 37541422

3D Printing Combined with Biopredictive Dissolution and PBPK/PD Modeling Optimization and Personalization of Pharmacotherapy: Are We There Yet?

Overview
Specialty Pharmacology
Date 2023 Aug 4
PMID 37541422
Authors
Affiliations
Soon will be listed here.
Abstract

Precision medicine requires selecting the appropriate dosage regimen for a patient using the right drug, at the right time. Model-Informed Precision Dosing (MIPD) is a concept suggesting utilization of model-based prediction methods for optimizing the treatment benefit-harm balance, based on individual characteristics of the patient, disease, treatment method, and other factors. Here, we discuss a theoretical workflow comprising several elements, beginning from the physiologically based pharmacokinetic/pharmacodynamic (PBPK/PD) models, through 3D printed tablets with the model proposed dose, information range and flow, and the patient themselves. We also describe each of these elements, and the connection between them, highlighting challenges and potential obstacles.

Citing Articles

Can 3D Printed Tablets Be Bioequivalent and How to Test It: A PBPK Model Based Virtual Bioequivalence Study for Ropinirole Modified Release Tablets.

Shuklinova O, Wyszogrodzka-Gawel G, Baran E, Lisowski B, Wisniowska B, Dorozynski P Pharmaceutics. 2024; 16(2).

PMID: 38399313 PMC: 10893163. DOI: 10.3390/pharmaceutics16020259.